Look Up > Drugs > Fexofenadine and Pseudoephedrine
Fexofenadine and Pseudoephedrine
Pronunciation
U.S. Brand Names
Generic Available
Pharmacological Index
Use
Pregnancy Risk Factor
Usual Dosage
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Dosage Forms

Pronunciation
(feks oh FEN a deen & soo doe e FED rin)

U.S. Brand Names
Allegra-D™

Generic Available

No


Pharmacological Index

Antihistamine/Decongestant Combination


Use

Relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. Symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion.


Pregnancy Risk Factor

C


Usual Dosage

Oral: Adults: One tablet twice daily for adults and children 12 years of age and older. It is recommended that the administration with food should be avoided. A dose of one tablet once daily is recommended as the starting dose in patients with decreased renal function.


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

Pseudoephedrine component: Use with caution since pseudoephedrine is a sympathomimetic amine which could interact with epinephrine to cause a pressor response


Dental Health: Effects on Dental Treatment

Pseudoephedrine component: Up to 10% of patients could experience tachycardia, palpitations, and dry mouth; use vasoconstrictor with caution


Patient Information

Patients should be instructed to take tablets only as prescribed. Do not exceed the recommended dose. If nervousness, dizziness, or sleeplessness occur, discontinue use and consult the physician. Patients should also be advised against the concurrent use of the tablets with over-the-counter antihistamines and decongestants. The product should not be used by patients who are hypersensitive to it or to any of its ingredients. Due to its pseudoephedrine component, this product should not be used by patients with narrow-angle glaucoma, urinary retention, or by patients receiving a monoamine oxidase (MAO) inhibitor or within 14 days of stopping use of MAO inhibitor. It also should not be used by patients with severe hypertension or severe coronary artery disease. Patients should be told that this product should be used in pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or nursing infant. Patients should be cautioned not to break or chew the tablet. Patients should be directed to swallow the tablet whole. Patients should be instructed not to take the tablet with food. Patients should also be instructed to store the medication in a tightly closed container in a cool, dry place, away from children.


Dosage Forms

Tablet, extended release: Fexofenadine hydrochloride 60 mg and pseudoephedrine hydrochloride 120 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved